Jane F. Barlow, MD, MPH, MBA, EVP & Chief Clinical Officer

Dr. Jane Barlow is a clinical and strategic executive with over 25 years of healthcare leadership experience. She is EVP and Chief Clinical Officer for Real Endpoints, where she focuses on evaluating the economic impact and value of pharmaceuticals and diagnostics to aid in defining access, coverage, and contracting strategies with a focus on outcomes.

Dr. Barlow is Senior Advisor to the MIT Center for Biomedical Innovation New Drug Development Paradigms Initiative project on Financing of Curative Therapies in the US (FoCUS).  As part of this initiative, she leverages her deep payer expertise to evaluate the impact of durable cell and gene therapies on payer financing and reimbursement strategies.  The MIT NEWDIGS consortium FoCUS Project seeks to understand the financial challenges durable cell and gene therapies may create and generates solutions to promote sustainable patient access. This multi-stakeholder effort gathers input from over 150 individuals from over 50 organizations including patient advocacy groups, payers from all segments of the US healthcare system, manufacturers, ALKs, regulators, and academics working in healthcare policy, financing, and reimbursement.

Before joining RE, Dr. Barlow served as Associate Chief Medical Officer for CVS Health where she drove clinical strategies supporting drug purchasing, distribution, and utilization management for over 5B prescriptions yearly including over $40B in specialty revenue. In addition, she was Chief Medical Officer for the 11M life Medicare and government services business segment and served on the Board of Directors for SilverScript Insurance Company. Dr. Barlow has also held leadership roles Medco Health Solutions, IBM, the U.S. military, federal government, industry, and private practice.

Dr. Barlow attended medical school at Creighton University and completed her residency training in occupational medicine at Johns Hopkins University. She holds masters’ degrees in business administration and public health and is a Certified Physician Executive with a certificate in Health Information Technology from the American Association of Physician Leaders. Dr. Barlow is board-certified in occupational medicine and is a fellow of both the American College of Occupational and Environmental Medicine and the American College of Preventive Medicine.  She serves on the board of directors of Momenta Pharmaceuticals, Inc. and the advisory board for Pictet Asset Management.  She previously served on the board of TherapeuticsMD.

Our Team

Jeffrey Berkowitz

CEO and Director

Mr. Berkowitz is one of the rare top executives whose career has spanned most key verticals in global healthcare -- with executive committee and....

read full biography >

Susan Raiola


Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting...

read full biography >

Roger Longman

Founder and Chairman

Roger Longman is co-founder and chairman of Real Endpoints LLC, a leading reimbursement-focused.....

read full biography >

Jane F. Barlow, MD, MPH, MBA

EVP & Chief Clinical Officer

Jane Barlow is a clinical and strategic executive with over 25 years of healthcare leadership...

read full biography >

Ryan Walsh

Vice President, Client Services

Ryan Walsh joins Real Endpoints as Vice President for Client Services.  In this capacity, Ryan is responsible for marketing and promotional.....

read full biography >

Beth Nash, MD

Chief Medical Officer

Dr. Beth Nash is Chief Medical Officer at Real Endpoints, where her team of pharmacists and biostatisticians has developed...

read full biography >

Amy Steinkellner, PharmD

Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoint team since 2012. She serves as senior clinical advisor to the research...

read full biography >

Robert Galvin, MD

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms...

read full biography >

Michael Sherman, MD

Dr. Michael Sherman serves as Chief Medical Officer and senior vice president for Harvard Pilgrim Health Care...

read full biography >

Dennis Purcell

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm...

read full biography >

Linda Blackerby

Linda has been serving as the President of Pharma Intelligence at Informa since May 2015, overseeing an income statement...

read full biography >

Arthur Pappas (Observer)

Art has over 30 years of experience as a pharmaceutical industry executive and venture capital investor in...

read full biography >